C2C Wealth Management’s DNA X Inc SONM Stock Holding History

C2C Wealth Management’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$217K	Buy	47,500 +12,000	+34%	+$42.8K	0.17%	85
2026 Q2	$183K	Buy	35,500 +15,500	+78%	+$68.8K	0.14%	92
2026 Q1	$80.6K	Buy	+20,000	New	+$94.4K	0.07%	90

C2C Wealth Management's SONM Position: Q3 2026 in Review

C2C Wealth Management increased its DNA X Inc (SONM) stake by 34% in Q3 2026, buying an estimated $42.8K and bringing the position to 47,500 shares worth $217K. The position accounts for 0.17% of the portfolio, ranked #85.

C2C Wealth Management first reported a position in SONM in Q1 2026 and has held it in 3 quarters since. 1 fund tracked by Wall St. Rank holds SONM as of Q3 2026.

C2C Wealth Management held 47,500 shares of DNA X Inc worth $217K as of Q3 2026.
C2C Wealth Management bought 12,000 DNA X Inc shares in Q3 2026, an estimated $42.8K.
DNA X Inc made up 0.17% of C2C Wealth Management's portfolio in Q3 2026, its #85 holding.
C2C Wealth Management first reported a position in DNA X Inc in Q1 2026 and has held it in 3 quarters since.
1 fund tracked by Wall St. Rank held DNA X Inc as of Q3 2026.

Based on C2C Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.